Results 131 to 140 of about 16,400 (171)

Post-treatment HBsAg decline predicts high rate of HBsAg loss after stopping entecavir or tenofovir in HBeAg-negative patients without retreatment

Digestive and Liver Disease, 2023
Little is known about the role of post-treatment HBsAg decline in HBsAg loss following nucleos(t)ide analogues cessation.HBeAg-negative patients without cirrhosis who previously received entecavir or tenofovir disoproxil fumarate (TDF) were enrolled (n=530).
Hsin-Wei Fang, Tsung-Hui Hu, Jing-Houng Wang, Chao-Hung Hung, Sheng-Nan Lu, Chien-Hung Chen   +5 more
openaire   +2 more sources

Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase

Clinics and Research in Hepatology and Gastroenterology, 2019
We aimed to assess the long-term outcomes of e antigen-negative chronic hepatitis B (CHB) infection with low hepatitis B virus (HBV) DNA level (
Li, Chen, Junjie, Shi, Zhonghua, Lu, Yun, Ye, Xinbei, Zhou, Youwen, Tan   +5 more
openaire   +2 more sources

Loss of HBsAg with interferon‐α therapy in chronic hepatitis D virus infection

Journal of Medical Virology, 1993
Eleven patients with chronic hepatitis D virus (HDV) infection who had chronic active hepatitis and HDV antigen on liver biopsy were randomised in a crossover therapeutic trial of interferon-alpha 2b vs. no therapy. Nine patients had a history of intravenous drug use (drug free > 6 months before therapy), 8 had histological evidence of cirrhosis, and 7
J Y, Lau, R, King, C J, Tibbs, A P, Catterall, H M, Smith, B C, Portmann, G J, Alexander, R, Williams   +7 more
openaire   +2 more sources

Abdominal pain and weight loss in an HBsAg positive 56-year-old Afghan woman

Journal of Clinical Virology, 2011
A 56-year-old Afghan woman presented with the complaints f abdominal pain, anorexia and significant weight loss since 2 onths ago. She was a known case of hepatitis B infection for ears with no further follow-up, who had received no therapy or this infection. On examination, she had a 38.4 ◦C oral temerature but the other vital signs were in the normal
Naderi, H. R., Yarani, M., Sheybani, F.
openaire   +2 more sources

HBcrAg, pg RNA and HBsAg dynamically supervise the seroconversion of HBsAg with anti-viral therapy: "Loss of HBsAg" maybe not a good end-point of anti-viral therapy.

Clinica chimica acta; international journal of clinical chemistry, 2020
We aimed to identify predictor of HBsAg seroconversion using serum quantitative pg-RNA, HBcrAg and HBsAg in CHB patients with anti-viral therapy.A total of 335 patients with anti-viral therapy between 2013 and 2017 were enrolled, only 23 achieved the seroconversion of HBsAg, other 138 patients without seroconversion of HBsAg were selected randomly in ...
Guanghua, Ma, Bin, Lou, Feifei, Lv, Dejian, Zhao, Hui, Chen, Xianfei, Ye, Yu, Chen   +6 more
openaire   +1 more source

Hepatocellular carcinoma and HBsAg loss after cessation of antiviral therapy

Liver International, 2022
Yun‐Fan Liaw, Wen‐Juei Jeng, Rong‐Nan Chien   +2 more
openaire   +2 more sources

Loss of HBsAg after interferon-α treatment: Cure of chronic hepatitis B virus?

Hepatology, 1991
Sixty-four patients with chronic hepatitis B who were treated with interferon-α (recombinant IFN-α-2a in 9 patients, recombinant IFN-α-2b in 50 patients and lymphoblastoid IFN-α-n1 in 5 patients) in protocols conducted at the Liver Diseases Section of the National Institutes of Health between 1984 and 1986 were observed with ...
openaire   +2 more sources

Quantification of HBsAg (HBsAg-Q) in HBeAg-Negative Patients Receiving Nucleos(T)ide Analogues to Predict the Loss of HBsAg

Journal of Hepatology, 2016
T. Broquetas, M. García-Retortillo, J.J. Hernández, M. Puigvehí, R. Fernández, N. Cañete, S. Coll, B. Cabrero, M.D. Giménez, F. Bory, R. Solà, J.A. Carrión   +11 more
openaire   +1 more source

Deletions in the HBV s gene are associated with altered HBsAg composition in patients with HBsAg loss during NA therapy

Zeitschrift für Gastroenterologie, 2021
M Pfefferkorn, D Deichsel, M Matz-Soja, T Berg, F van Bömmel   +4 more
openaire   +1 more source

Kinetics of Hbsag Loss in Nucleoside Analogue and Interferon Therapies

Gastroenterology, 2017
Daniel Suarez, Michelle Ferreira, Sungyoung Auh, Yunet Calderon, Aubrey Garrett, Saeed Jortani, Marc G. Ghany   +6 more
openaire   +1 more source